New Results
Glutamine-addiction in cisplatin resistant cancer cells is mediated by SLC7A11 and can be targeted with asparaginase therapy
View ORCID ProfileJiantao Wang, View ORCID ProfileRobert Strauss, View ORCID ProfileJiri Bartek, View ORCID ProfileSean G Rudd
doi: https://doi.org/10.1101/2024.07.19.604261
Jiantao Wang
1Science for Life Laboratory (SciLifeLab), Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
2Department of Radiation Oncology, West China Hospital, Sichuan University, Chengdu, China
3Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China
Robert Strauss
4Danish Cancer Institute, Genome Integrity Group, Copenhagen, Denmark
Jiri Bartek
4Danish Cancer Institute, Genome Integrity Group, Copenhagen, Denmark
5Science for Life Laboratory (SciLifeLab), Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
Sean G Rudd
1Science for Life Laboratory (SciLifeLab), Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Article usage
Posted July 22, 2024.
Glutamine-addiction in cisplatin resistant cancer cells is mediated by SLC7A11 and can be targeted with asparaginase therapy
Jiantao Wang, Robert Strauss, Jiri Bartek, Sean G Rudd
bioRxiv 2024.07.19.604261; doi: https://doi.org/10.1101/2024.07.19.604261
Subject Area
Subject Areas
- Biochemistry (13354)
- Bioengineering (10171)
- Bioinformatics (32530)
- Biophysics (16739)
- Cancer Biology (13823)
- Cell Biology (19650)
- Clinical Trials (138)
- Developmental Biology (10620)
- Ecology (15717)
- Epidemiology (2067)
- Evolutionary Biology (20022)
- Genetics (13217)
- Genomics (18347)
- Immunology (13457)
- Microbiology (31494)
- Molecular Biology (13119)
- Neuroscience (68643)
- Paleontology (509)
- Pathology (2127)
- Pharmacology and Toxicology (3669)
- Physiology (5723)
- Plant Biology (11783)
- Synthetic Biology (3303)
- Systems Biology (8026)
- Zoology (1813)